{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:24:37Z","timestamp":1790490277944,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Health Research Board","award":["HRA_POR 2012\/99"],"award-info":[{"award-number":["HRA_POR 2012\/99"]}]},{"DOI":"10.13039\/501100001593","name":"Irish Cancer Society","doi-asserted-by":"publisher","award":["PCI12TAN"],"award-info":[{"award-number":["PCI12TAN"]}],"id":[{"id":"10.13039\/501100001593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"European Commission Seventh Framework Programme","doi-asserted-by":"publisher","award":["PIAP-GA-2013-612219-VIP"],"award-info":[{"award-number":["PIAP-GA-2013-612219-VIP"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Breakthrough Cancer Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jconrel.2015.11.030","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T07:49:38Z","timestamp":1449128978000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria"],"prefix":"10.1016","volume":"222","author":[{"given":"Panos","family":"Lehouritis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Jeavons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-1260","authenticated-orcid":false,"given":"Mark","family":"Tangney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.11.030_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-9378-8-11","article-title":"Bacteria and tumours: causative agents or opportunistic inhabitants?","volume":"8","author":"Cummins","year":"2013","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/156652310790945575","article-title":"Tumour targeting with systemically administered bacteria","volume":"10","author":"Morrissey","year":"2010","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4161\/bbug.1.6.13146","article-title":"Bacteria as vectors for gene therapy of cancer","volume":"1","author":"Baban","year":"2010","journal-title":"Bioeng. Bugs"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.0408422102","article-title":"Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4161\/bbug.1.2.10286","article-title":"Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice","volume":"1","author":"Stritzker","year":"2010","journal-title":"Bioeng. Bugs"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrmicro777","article-title":"Clostridia in cancer therapy","volume":"1","author":"Minton","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/0008-5472.CAN-09-3453","article-title":"Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer","volume":"70","author":"Nguyen","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cgt.7700634","article-title":"Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients","volume":"10","author":"Nemunaitis","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0045","doi-asserted-by":"crossref","first-page":"249ra111","DOI":"10.1126\/scitranslmed.3008982","article-title":"Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses","volume":"6","author":"Roberts","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0050","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/sj.bjc.6600911","article-title":"A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs","volume":"88","author":"Spooner","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0169-409X(97)00032-X","article-title":"Antibody-directed enzyme prodrug therapy (ADEPT): a review","volume":"26","author":"Springer","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0060","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1158\/0008-5472.CAN-07-0297","article-title":"Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2","volume":"67","author":"Schepelmann","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2013.05.005","article-title":"Bacterial-directed enzyme prodrug therapy","volume":"170","author":"Lehouritis","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0075","first-page":"1594","volume":"12","author":"Cunningham","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0080","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1158\/1078-0432.CCR-07-4800","article-title":"Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy","volume":"14","author":"Friedlos","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0085","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/mt.2010.59","article-title":"Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors","volume":"18","author":"Cronin","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030940","article-title":"High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting","volume":"7","author":"Cronin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0095","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/mt.2014.23","article-title":"Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy","volume":"22","author":"Cronin","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0100","first-page":"195","article-title":"Gene therapy for cancer: dairy bacteria as delivery vectors","volume":"10","author":"Tangney","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00253-011-3787-0","volume":"94","author":"Valle","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ijc.11464","article-title":"Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy","volume":"107","author":"Somers","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/mt.2009.66","article-title":"Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth","volume":"17","author":"Ahmad","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0120","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.bjc.6605094","article-title":"E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954","volume":"100","author":"Vass","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0125","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.bjc.6601612","article-title":"2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT","volume":"90","author":"Helsby","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2015.11.030_bb0130","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bcp.2009.10.008","article-title":"Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954","volume":"79","author":"Prosser","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0135","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1089\/hum.1997.8.14-1637","article-title":"In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase","volume":"8","author":"Parker","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.11.030_bb0140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0026-895X(25)13624-9","article-title":"A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase","volume":"43","author":"Austin","year":"1993","journal-title":"Mol. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915302509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915302509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T17:04:12Z","timestamp":1748711052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915302509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":27,"alternative-id":["S0168365915302509"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.030","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}